Large-cap Health Care company Merck & has logged a -2.8% change today on a trading volume of 15,896,372. The average volume for the stock is 11,264,734.
Merck & Co., Inc. operates as a healthcare company worldwide. Based in Rahway, United States the company has 70,000 full time employees and a market cap of $247,702,339,584. Merck & currently offers its equity investors a dividend that yields 3.0% per year.
The company is now trading -22.01% away from its average analyst target price of $125.55 per share. The 24 analysts following the stock have set target prices ranging from $100.0 to $150.0, and on average give Merck & a rating of buy.
Over the last 12 months MRK shares have declined by -18.0%, which represents a difference of -41.6% when compared to the S&P 500. The stock's 52 week high is $134.63 per share and its 52 week low is $94.48. With its net margins declining an average -41.4% over the last 6 years, Merck & declining profitability gives us reason to believe its stock price will continue to underwhelm.
| Date Reported | Total Revenue ($ k) | Net Profit ($ k) | Net Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2023 | 60,115,000 | 365,000 | 1 | -95.83 |
| 2022 | 59,283,000 | 14,519,000 | 24 | -11.11 |
| 2021 | 48,704,000 | 13,049,000 | 27 | 58.82 |
| 2020 | 41,518,000 | 7,067,000 | 17 | -32.0 |
| 2019 | 39,121,000 | 9,843,000 | 25 | 66.67 |
| 2018 | 42,294,000 | 6,220,000 | 15 |
